The aberrant regulation of NF-κB has been implicated in numerous autoimmune and inflammatory diseases including rheumatoid arthritis (RA), diabetes (DM), inflammatory bowel disease (IBD), heart disease, and multiple sclerosis (MS) [13,14,15,16,17,18,19]. This evidence concerns the gene NFKB1 and inflammatory bowel disease.